Toll-like Receptor 9 (TLR9) suppression restores endothelial function in the maternal placental microvasculature in preeclampsia

被引：0
|
作者：
De La Pena, Rosinda [1 ]
Kozak, Kaleigh [2 ]
Gutterman, David D. [2 ]
Sigmund, Curt D. [2 ]
Beyer, Andreas M. [2 ]
Widlansky, Michael E. [2 ]
Freed, Julie [2 ]
Cruz, Meredith [2 ]
McIntosh, Jennifer J. [2 ]
机构：
[1] Hosp, Wauwatosa, WI USA
[2] Med Coll Wisconsin, Milwaukee, WI USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2024年 / 230卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
865
引用
收藏
页码：S458 / S459
页数：2
相关论文
共 50 条
  • [31] Electronic Cigarettes Induce Mitochondrial DNA Damage and Trigger TLR9 (Toll-Like Receptor 9)-Mediated Atherosclerosis
    Li, Jieliang
    Huynh, Luong
    Cornwell, William D.
    Tang, Moon-Shong
    Simborio, Hannah
    Huang, Jing
    Kosmider, Beata
    Rogers, Thomas J.
    Zhao, Huanqing
    Steinberg, Michael B.
    Le, Le Thu Thi
    Zhang, Lanjing
    Kien Pham
    Liu, Chen
    Wang, He
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (02) : 839 - 853
  • [32] Toll-like Receptor 9 (TLR9) Plays a Key Role in the Autonomic Cardiac and Baroreflex Control of Arterial Pressure
    Rodrigues, Fernanda L.
    Bomfim, Gisele F.
    Silva, Carlos A.
    Fazan Jr, Rubens
    Tostes, Rita C.
    Carneiro, Fernando S.
    HYPERTENSION, 2013, 62 (03)
  • [33] Selectively targeting the toll-like receptor 9 (TLR9) - IRF 7 signaling pathway by polymer blend particles
    Chen, Helen C.
    Zhan, Xi
    Tran, Kenny K.
    Shen, Hong
    BIOMATERIALS, 2013, 34 (27) : 6464 - 6472
  • [34] Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma
    Karime, Christian
    Wang, Jing
    Woodhead, Gregory
    Mody, Kabir
    Hennemeyer, Charles T.
    Borad, Mitesh J.
    Mahadevan, Daruka
    Chandana, Sreenivasa R.
    Babiker, Hani
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (01) : 1 - 13
  • [35] The role of toll-like receptor 9 (TLR9) in Epstein-Barr virus-associated gastric cancer
    Dworzanska, Anna
    Strycharz-Dudziak, Malgorzata
    Dworzanski, Jakub
    Stec, Agnieszka
    Rajtar, Barbara
    Drop, Bartlomiej
    Polz-Dacewicz, Malgorzata
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2020, 33 (02) : 106 - 111
  • [36] Toll-Like Receptor-9 (TLR9) is Requisite for Acute Inflammatory Response and Injury Following Lung Contusion
    Suresh, Madathilparambil V.
    Thomas, Bivin
    Dolgachev, Vladislav A.
    Sherman, Matthew A.
    Goldberg, Rebecca
    Johnson, Mark
    Chowdhury, Aulina
    Machado-Aranda, David
    Raghavendran, Krishnan
    SHOCK, 2016, 46 (04): : 412 - 419
  • [37] Toll-Like Receptor 9 (TLR9) Inhibition Attenuates Chronic Stress-Induced Social Behavior Deficits
    Jose, Dania
    Madeshiya, Amit Kumar
    Tripathi, Ashutosh
    Todd, Tela
    Quevedo, Joao
    Pillai, Anilkumar
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S180 - S180
  • [38] A TOLL-LIKE RECEPTOR 9 (TLR9) SINGLE NUCLEOTIDE POLYMORPHISM MAY INCREASE COMPLICATIONS TO HELICOBACTER PYLORI INFECTION
    Balogun, Rilwan
    Ding, Lin
    Mallick, Palash
    Borgstrom, Mark
    Gavini, Hemanth K.
    Leal, Rolando J.
    Taleban, Sasha
    Babaria, Radhika
    Merchant, Juanita L.
    GASTROENTEROLOGY, 2023, 164 (06) : S801 - S801
  • [39] Toll-like receptor 9 (TLR9) activation by CpG or pDNA ameliorates hepatic fibrosis associated with lymphocyte alterations
    Axelrod, Jonathan H.
    Khvalevsky, Elena
    Doron, Sarit
    Enk, Jonathan
    Melhem, Alaa
    Nechemia, Yael
    Pappo, Orit
    Haj, Madi
    Galun, Eithan
    Safadi, Rifaat
    HEPATOLOGY, 2006, 44 (04) : 575A - 575A
  • [40] TLR9 (Toll-Like Receptor 9) Agonist Suppresses Angiogenesis by Differentially Regulating VEGFA (Vascular Endothelial Growth Factor A) and sFLT1 (Soluble Vascular Endothelial Growth Factor Receptor 1) in Preeclampsia
    He, Biwei
    Yang, Xingyu
    Li, Yamei
    Huang, Ding
    Xu, Xin
    Yang, Wenjun
    Dai, Yan
    Zhang, Huijuan
    Chen, Zhengjun
    Cheng, Weiwei
    HYPERTENSION, 2018, 71 (04) : 671 - 680
12345